ArticleScientific reports2026
Enhanced cervical cancer diagnosis using a novel Bayesian fusion ensemble method with explainable AI.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is one of the leading causes of death in women, especially in low- and middle-income countries. Early disease detection is crucial for improving survival, but conventional methods are inefficient, costly, and error-prone. In this study, we present a hybrid machine learning framework that diagnoses cervical cancer risk from clinical and behavioral records by analyzing 36 patient attributes such as age, sexual history, smoking habit, hormonal contraceptive use, and sexually transmitted disease history. Missing values were imputed using a Generative Adversarial Imputation Network (GAIN). The Boruta algorithm was then used to identify the most influential diagnostic features, and Random Oversampling (ROS) was applied to correct class imbalance. Dimensional reduction techniques such as Independent Component Analysis (ICA) and Principal Component Analysis (PCA) were used. The diagnostic prediction is generated by a Bayesian Fusion Ensemble (XBFE) that combines outputs from Decision Tree and Random Forest models to estimate each patient’s likelihood of cervical cancer and systematically evaluates contributing risk factors. Principal determinants, including the Schiller test, the Hinselmann test, cytology, age, number of sexual partners, and smoking, were identified using Boruta feature selection. The proposed model achieved an accuracy of 99.88%, a recall of 1.00, and an AUC-ROC score of 1.00, as validated by K-fold cross-validation. To improve interpretability for healthcare clinicians, Explainable AI (XAI) tools such as SHAP and LIME were used. We developed a web-based application for real-time risk estimation. The proposed system provides a reliable and interpretable solution for predicting cervical cancer risk, helping doctors make better decisions, especially in resource-limited settings. human readable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.